Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

NCT02584140 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

136

Enrollment

OTHER

Sponsor class

Conditions

HIV Prevention

Interventions

BEHAVIORAL: Text Messaging
BEHAVIORAL: Adherence Counseling
DRUG: Daily Oral PrEP

Sponsor

University of California, Los Angeles

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]